1. Duan, H L, Peng, J, Pang, N, Guang, S Q, Yin, F. . [A case of Okur-Chung syndrome caused by CSNK2A1 gene variation and review of literature]. In Zhonghua er ke za zhi = Chinese journal of pediatrics, 57, 368-372. doi:10.3760/cma.j.issn.0578-1310.2019.05.010. https://pubmed.ncbi.nlm.nih.gov/31060130/
2. Kataoka, Keisuke, Nagata, Yasunobu, Kitanaka, Akira, Shimoda, Kazuya, Ogawa, Seishi. 2015. Integrated molecular analysis of adult T cell leukemia/lymphoma. In Nature genetics, 47, 1304-15. doi:10.1038/ng.3415. https://pubmed.ncbi.nlm.nih.gov/26437031/
3. Blanc, Albin, Bonnet, Céline, Wandzel, Marion, Philippe, Christophe, Lambert, Laëtitia. 2024. Patient with a heterozygous pathogenic variant in CSNK2A1 gene: A new case to update the Okur-Chung neurodevelopmental syndrome. In American journal of medical genetics. Part A, 194, e63642. doi:10.1002/ajmg.a.63642. https://pubmed.ncbi.nlm.nih.gov/38711237/
4. Yu, Zhengyao, He, Huijuan, Jiang, Baoying, Hu, Jing. 2024. O-GlcNAcylation of CSNK2A1 by OGT is Involved in the Progression of Colorectal Cancer. In Molecular biotechnology, 67, 272-283. doi:10.1007/s12033-024-01049-1. https://pubmed.ncbi.nlm.nih.gov/38289573/
5. Jiang, Chao, Ma, Zhenghong, Zhang, Guoan, Du, Qin, Wang, Weibo. 2019. CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway. In Cancer management and research, 11, 10135-10143. doi:10.2147/CMAR.S222620. https://pubmed.ncbi.nlm.nih.gov/31819646/